Mereo BioPharma (MREO) Non-Current Assets (2017 - 2026)
Mereo BioPharma (MREO) recorded Non-Current Assets of $1.31 million in Q2 2026, up 8.5% from $1.21 million a year earlier and up 126.4% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma reported Non-Current Assets of $897,000, down 44.9% from FY2024.
- Annual Non-Current Assets has a three-year compound annual growth rate of -26.0% (FY2022 to FY2025).
- Across earlier years, Non-Current Assets came in at $1.63 million in FY2024 (-40.6%), $2.74 million in FY2023 (+23.6%) and $2.22 million in FY2022.
- The Q2 2026 figure is the highest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last seven quarters, with an average decline of 37.7%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 8.5% in Q2 2026, against a decline of 59.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $580,000 (Q1 2026), $897,000 (Q4 2025) and $1.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Mereo BioPharma | 46.45 Mn | -103.46 Mn | - | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 580,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Jun 30, 2020 | 53.06 Mn |
| Dec 31, 2019 | 73.45 Mn |
| Jun 30, 2019 | 73.86 Mn |
| Dec 31, 2018 | 41.61 Mn |
| Dec 31, 2017 | 44.57 Mn |
API Access
Mereo BioPharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();